| ID Source | ID |
|---|---|
| PubMed CID | 95803 |
| CHEMBL ID | 270946 |
| SCHEMBL ID | 880169 |
| MeSH ID | M0135807 |
| Synonym |
|---|
| 8045-27-0 |
| 6-butoxy-9h-purin-2-amine |
| o6-substituted guanine deriv. 4 |
| bdbm5462 |
| chembl270946 , |
| purine, 2-amino-6-butoxy- |
| nsc37366 |
| nsc-37366 |
| 76412-62-9 |
| nsc 37366 |
| 6-butoxy-7h-purin-2-amine |
| o(6)-butylguanine |
| 1h-purin-2-amine, 6-butoxy- |
| o(6)-n-butylguanine |
| SCHEMBL880169 |
| mfcd20482035 |
| 2-amino-6-butoxy-9h-purine |
| SPHOZXNZJHRHSL-UHFFFAOYSA-N |
| o6-butylguanine |
| 6-butoxy-3,9-dihydro-2h-purin-2-imine |
| DTXSID80997808 |
| Protein | Taxonomy | Measurement | Average | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| Cyclin-dependent kinase 1 | Homo sapiens (human) | IC50 (µMol) | 32.0000 | 0.0004 | 1.3452 | 10.0000 | AID320943; AID53352 |
| G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | IC50 (µMol) | 32.0000 | 0.0013 | 1.4518 | 10.0000 | AID320943; AID53352 |
| G2/mitotic-specific cyclin-B | Marthasterias glacialis (spiny starfish) | IC50 (µMol) | 40.0000 | 0.0040 | 2.1093 | 9.4000 | AID1795776 |
| Methylated-DNA--protein-cysteine methyltransferase | Homo sapiens (human) | IC50 (µMol) | 493.0000 | 0.0030 | 0.3779 | 2.6000 | AID31150 |
| Cyclin-A2 | Homo sapiens (human) | IC50 (µMol) | 42.6667 | 0.0004 | 1.0339 | 10.0000 | AID1795776; AID53534 |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | IC50 (µMol) | 42.6667 | 0.0004 | 1.0444 | 10.0000 | AID1795776; AID53534 |
| Cyclin-A1 | Homo sapiens (human) | IC50 (µMol) | 48.0000 | 0.0005 | 1.4715 | 10.0000 | AID53534 |
| Cyclin-dependent kinase 1 | Oryzias latipes (Japanese medaka) | IC50 (µMol) | 40.0000 | 0.0040 | 2.1093 | 9.4000 | AID1795776 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 5 (45.45) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.72) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 11 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||